Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation
December 16, 2014 08:38 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the continued expansion of Elite's intellectual property...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014
June 30, 2014 14:05 ET | Elite Pharmaceuticals, Inc.
Revenues Increase by 35%, Product Development Accelerating Conference Call Scheduled for Tuesday, July 1 at 12:00 PM EDT NORTHVALE, N.J., June 30, 2014 (GLOBE NEWSWIRE) -- Elite...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Secures Funding Commitment of Up to $40 Million From Lincoln Park Capital Fund, LLC
April 14, 2014 07:30 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 14, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that it has entered into a common stock purchase agreement with...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201
December 05, 2013 12:49 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pilot bioequivalence study in...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Naltrexone Hydrochloride
September 18, 2013 07:51 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 18, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the initial shipment of naltrexone hydrochloride 50 mg tablets...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Awarded Second U.S. Patent for Abuse Resistant Drug Formulation
April 23, 2013 08:23 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 23, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the issuance of U.S. Patent No. 8,425,933 entitled...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, LLC
April 22, 2013 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 22, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that it has entered into a $10 million common stock purchase...